Genomics

Dataset Information

0

STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment


ABSTRACT: A fascinating but uncharacterized action of antimitotic chemotherapy is to collectively prime cancer cells to apoptotic mitochondrial outer membrane permeabilization (MOMP), while impacting only on cycling cell subsets. Here, we show that a proapoptotic secretory phenotype is induced by activation of cGAS/STING in cancer cells that are hit by antimitotic treatment, accumulate micronuclei and maintain mitochondrial integrity despite intrinsic apoptotic pressure. Organotypic cultures of primary human breast tumors and patient-derived xenografts sensitive to paclitaxel exhibit gene expression signatures typical of type I IFN and TNFalpha exposure. These cytokines induced by cGAS/STING activation trigger NOXA expression in neighboring cells and render them acutely sensitive to BCL-xL inhibition. cGAS/STING-dependent apoptotic effects are required for paclitaxel response in vivo, and they are amplified by sequential, but not synchronous, administration of BH3 mimetics. Thus anti-mitotic agents propagate apoptotic priming across heterogeneously sensitive cancer cells through cytosolic DNA sensing pathway-dependent extracellular signals, exploitable by delayed MOMP targeting.

ORGANISM(S): Homo sapiens

PROVIDER: GSE140489 | GEO | 2019/11/21

REPOSITORIES: GEO

Similar Datasets

2023-08-16 | GSE235225 | GEO
2023-12-15 | PXD040192 | Pride
2023-08-16 | GSE196610 | GEO
2018-05-01 | GSE104602 | GEO
2022-10-01 | GSE186088 | GEO
2024-04-25 | GSE261373 | GEO
2022-06-23 | MSV000089711 | MassIVE
2014-12-03 | E-GEOD-63794 | biostudies-arrayexpress
2014-12-03 | GSE63794 | GEO
2022-12-09 | GSE207458 | GEO